Plasma Proteins, - Components

Heparinoids and mucopolysaccharides react with, and modify, many of the plasma proteins. Heparin combines with fibrinogen, globulins and albumin. As judged by electrophoresis and various types of analysis and staining, the particular plasma protein components with which heparin combines are dependent upon the concentration of protein, concentration of heparin, pH value, and salts present. This explains the somewhat contradictory statements in literature about combinations of heparin with plasma proteins. The combination may result in change of solubility of the protein and reverse protein tests . Heparin can modify the murexide reaction for calcium in serum by affecting the calcium-protein-heparin complex. Many heparinoids... 

Fig. la Electrophoretic studicB on known mixtures of purified human plasma protein components. Rrom Armstrong, Budka and Morrison (4). 

The content of lipoproteins in many plasma fractions is readily followed by determining the cholesterol content, which may be extremely high (of the order of 20%) in some of the lipoproteins of plasma these include both an a- and a j9-globulin component. Both of these, in addition, contain large amounts of phosphatides and some fatty acid, so that phosphorus and fatty add determinations may also be of great value as anal3Ttical tools in discriminating these from other plasma protein components. 

Purification. Hemoglobin is provided by the red blood ceU in highly purified form. However, the red ceU contains many enzymes and other proteins, and red ceU membranes contain many components that could potentially cause toxicity problems. Furthermore, plasma proteins and other components could cause toxic reactions in recipients of hemoglobin preparations. The chemical modification reactions discussed herein are not specific for hemoglobin and may modify other proteins as well. Indeed, multifimctional reagents could actually couple hemoglobin to nonhemoglobin proteins. 

Biomedical Applications Due to their excellent blood compatibility (low interaction with plasma proteins) and high oxygen and moisture permeabilities, siloxane containing copolymers and networks have been extensively evaluated and used in the construction of blood contacting devices and contact lenses 376). Depending on the actual use, the desired mechanical properties of these materials are usually achieved by careful design and selection of the organic component in the copolymers. 

More is known about nitrogen. In a study of modern humans where diet components (protein, lipid and carbohydrate) were measured against the corresponding body components, a shift of between 4.2 and 4.4%o was observed for nitrogen in both plasma protein and hair (Schoeller et al. 1986). This is just outside the usual 3-4%o range. Salmon fishers from coastal British Columbia are enriched by 3%o compared to their diet (Chisholm et al. 1983). Ancient Mexicans have constant 8 N values, as reported by DeNiro and Epstein (1981) 8-10%o, and While and Schwarcz (1989) 9.8 0.8%o. In the latter... 

Scherphof, G., Damen, J., and Hoekstra, D. (1981). Interactions of liposomes with plasma proteins and components of the immune system, in Liposomes From Physical Structure to Therapeutic Applications (C. G. Knight, ed.), Elsevier, Amsterdam, pp. 299-322. 

There are receptors (TfRs) on the surfaces of many cells for transferrin, it binds to these receptors and is internalized by receptor-mediated endocytosis (compare the fate of LDL Chapter 25). The acid pH inside the lysosome causes the iron to dissociate from the protein. The dissociated iron leaves the endosome via DMTl to enter the cytoplasm. Unlike the protein component of LDL, apoTf is not degraded within the lysosome. Instead, it remains associated with its receptor, returns to the plasma membrane, dissociates from its receptor, reenters the plasma, picks up more iron, and again delivers the iron to needy ceils. 

Normally, 88% to 92% of phenytoin is bound to plasma protein, leaving 8% to 12% unbound. The unbound component is able to leave the blood to produce the clinical effect in the CNS, produce dose-related side effects in the CNS and at other sites, distribute to other peripheral sites, and be metabolized. Certain patient groups are known to have decreased protein binding, resulting in an increased percentage of drug that is unbound. These patient groups include ... 

Complexes with Other Plasma Proteins and Cellular Components... 

Hydrophobically modified HA derivatives,91 obtained through the partial esterification of the HA carboxyl groups with methylprednisolone (45% in HYCp45 and 60% in HYCp60),92 have been deeply studied 93 A key point prior to any in vivo study of the biomaterial is the assessment of the so-called "stealth character" of the species itself. Such characteristic corresponds to be invisible towards the immune system, so that colloids are not recognized as foreign objects by body fluid components, as plasma proteins fibrinogen, BSA and lipidic components.94,95... 

Another major protein component of clathrin-coated vesicles, generally known as adaptins, bind and link clathrin coats to the membrane [5], Multiple types of adaptins have been described, each type binding a unique set of cargo receptors and associated to a specific membrane organelle. Different sets of adaptins participate in forming the coat assembly complexes for the Golgi (API) and the plasma membrane (AP2). Sequential assembly and... 

A study of the potency of the antibiotic daptomycin cited plasma protein binding of 92%, but it claimed only a 2-fold shift in potency in serum (expected 12-fold) [68]. This type of discrepancy is relatively common and can often reflect substantial binding to components in the "serum-free" media. In the cases of HIV-directed non-nucleotide reverse transcriptase inhibitors, this has been dealt with by measuring the unbound drug concentration in the "serum-free" medium and using that data to calculate the intrinsic, serum-free potency [69]. 

The complement system comprises twenty plasma proteins present in the blood and in most bodily fluids. They are normally present in an inactive form but become activated via two separate pathways the classical pathway, which requires antibody, and the alternative pathway, which does not. Once the initial components of complement are activated, a cascade reac-... 

---